Copenhagen Infrastructure Partners to finalise construction of Tønder Biogas

Copenhagen Infrastructure Partners through its CI Advanced Bioenergy Fund I (CI ABF I) today announced the signing of an Engineering, Procurement & Construction contract for the completion of its Tønder Biogas facility. COPENHAGEN, Denmark, June 12, 2023 (GLOBE NEWSWIRE) — Copenhagen Infrastructure Partners (CIP) and Danish biogas technology provider, Lundsby Renewable Solutions A/S (Lundsby), have […]

Read More

Gorilla Technology Group Signs Heads of Terms to Acquire Bacom Internetwork

–Bolsters global expansion strategy– –Entry point to provide Smart City solutions in Thailand– LONDON, June 12, 2023 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI-based edge video analytics, IoT technologies, and cybersecurity, today announced that it agreed to binding terms to acquire Bacom Internetwork, a leading pioneer, distributor […]

Read More

Legality and Merit Prize, projects awarded in Rome’s Luiss University by the Italian Ministers

Paola Severino Stimulating dialogue between the university and high school students, combating educational poverty, and promoting the transmission of values such as legality, the fight against corruption, mutual respect, environmental protection, and culture while fostering individual talent – the project Legalità e Merito (Legality and Merit), born from an idea by Luiss Guido Carli’s Vice […]

Read More

Arbor Metals Completes Comprehensive Spectral Analysis of the Jarnet Lithium Project in James Bay, Quebec

Map Image of Arbor Metals’ Jarnet Lithium Project VANCOUVER, British Columbia, June 12, 2023 (GLOBE NEWSWIRE) — Arbor Metals Corp. (“Arbor” or the “Company”) (TSXV: ABR, FWB: 432) announces the successful completion of a detailed spectral analysis of the Jarnet Lithium project located in the James Bay region of Quebec. This comprehensive study marks a […]

Read More

Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness

PRESS RELEASE Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness New leading gene therapy company created combining late-stage X-linked retinitis pigmentosa (XLRP) program from AGTC, a preclinical program spun out from the University of Oxford and a second preclinical program to […]

Read More